Human lifespan could soon pass 100 years thanks to tech, says BofA - (CNBC via NewsPoints Desk)

  • Bank of America analysts Felix Tran and Haim Israel identified therapies that delay human death as a bourgeoning research area, CNBC reported Wednesday.

  • The analysts stated that companies such as Novartis are on the cusp of "bringing unprecedented increases to the quality and length of human lifespans," adding that their advances could expand human longevity well into the 100s.

  • "Medical knowledge will double every 73 days by 2020 vs. every 3.5 [years] in 2010, and genomic sequencing costs have fallen 99.999 percent since 2003," stated Israel and Tran, adding "this has enabled a new frontier in precision medicine to further extend life expectancy, heralding a 'techmanity' revolution."

  • The analysts suggested that genomics, which is expected to be a $41 billion industry by 2025, will provide the "next generation of gene editing technology offering potentially revolutionary advances in prevention and disease treatments."

  • Meanwhile, Israel and Tran remarked that the "ammortality" theme, expected to be worth $504 billion by 2025, "will help to improve health spans & [lifespans] to the betterment of human vitality, enabling the world population to live freer of disease rather than forever."

  • FirstWord Reports: Providing insight, analysis and expert opinion on important Pharma trends and challenging issues <Click here>

To read more NewsPoints articles, click here.